Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 1216 AL 1230

Therapeutic Applications of Botulinum Neurotoxin for Autonomic Symptoms in Parkinson's Disease: An Updated Review

Mitchell SD, Sidiropoulos C.

Toxins (Basel). 2021 Mar 19;13(3):226. doi: 10.3390/toxins13030226.

Mechanisms of Neurodegeneration in Various Forms of Parkinsonism-Similarities and Differences

Koziorowski D, Figura M, Milanowski ŁM, Szlufik S, Alster P, Madetko N, Friedman A.

Cells. 2021 Mar 16;10(3):656. doi: 10.3390/cells10030656.

Calmodulin and Its Binding Proteins in Parkinson's Disease

Bohush A, Leśniak W, Weis S, Filipek A.

Int J Mol Sci. 2021 Mar 16;22(6):3016. doi: 10.3390/ijms22063016.

Could Small Heat Shock Protein HSP27 Be a First-Line Target for Preventing Protein Aggregation in Parkinson's Disease?

Navarro-Zaragoza J, Cuenca-Bermejo L, Almela P, Laorden ML, Herrero MT.

Int J Mol Sci. 2021 Mar 16;22(6):3038. doi: 10.3390/ijms22063038.

Brain Insulin Resistance: Focus on Insulin Receptor-Mitochondria Interactions

Pomytkin I, Pinelis V.

Life (Basel). 2021 Mar 22;11(3):262. doi: 10.3390/life11030262.

Dopamine: The Neuromodulator of Long-Term Synaptic Plasticity, Reward and Movement Control

Speranza L, di Porzio U, Viggiano D, de Donato A, Volpicelli F.

Cells. 2021 Mar 26;10(4):735. doi: 10.3390/cells10040735.

Validation of Cognitive Rehabilitation as a Balance Rehabilitation Strategy in Patients with Parkinson's Disease: Study Protocol for a Randomized Controlled Trial

Arroyo-Ferrer A, Sánchez-Cuesta FJ, González-Zamorano Y, Del Castillo MD, Sastre-Barrios C, Ríos-Lago M, Romero JP.

Medicina (Kaunas). 2021 Mar 26;57(4):314. doi: 10.3390/medicina57040314.

Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis

Root J, Merino P, Nuckols A, Johnson M, Kukar T.

Neurobiol Dis. 2021 Jul;154:105360. doi: 10.1016/j.nbd.2021.105360. Epub 2021 Mar 31.

Deep brain stimulation outcomes in the malignant end of Parkinson's disease spectrum

Artusi CA, Romagnolo A, Imbalzano G, Montanaro E, Zibetti M, Rizzone MG, Lopiano L.

Parkinsonism Relat Disord. 2021 May;86:5-9. doi: 10.1016/j.parkreldis.2021.03.017. Epub 2021 Mar 28.

The gut-brain connection in the pathogenicity of Parkinson disease: Putative role of autophagy

Kakoty V, K C S, Dubey SK, Yang CH, Kesharwani P, Taliyan R.

Neurosci Lett. 2021 May 14;753:135865. doi: 10.1016/j.neulet.2021.135865. Epub 2021 Apr 1.

Metals associated neurodegeneration in Parkinson's disease: Insight to physiological, pathological mechanisms and management

Raj K, Kaur P, Gupta GD, Singh S.

Neurosci Lett. 2021 May 14;753:135873. doi: 10.1016/j.neulet.2021.135873. Epub 2021 Apr 1.

'Striving for normality' when coping with Parkinson's disease in everyday life: A metasynthesis

Haahr A, Groos H, Sørensen D.

Int J Nurs Stud. 2021 Jun;118:103923. doi: 10.1016/j.ijnurstu.2021.103923. Epub 2021 Mar 4.

Changes in prefrontal cortical activity and turning in response to dopaminergic and cholinergic therapy in Parkinson's disease: A randomized cross-over trial

Vitorio R, Stuart S, Giritharan A, Quinn J, Nutt JG, Mancini M.

Parkinsonism Relat Disord. 2021 May;86:10-14. doi: 10.1016/j.parkreldis.2021.03.014. Epub 2021 Mar 27.

Involuntary moaning in a Hispanic family with eight affected members

Gisatulin M, Rossi M, Perandones C, Klein C, Lohmann K, Merello M.

Parkinsonism Relat Disord. 2021 Aug;89:206-208. doi: 10.1016/j.parkreldis.2021.03.023. Epub 2021 Mar 26.

Smartphones for Remote Symptom Monitoring of Parkinson's Disease

Little MA.

J Parkinsons Dis. 2021;11(s1):S49-S53. doi: 10.3233/JPD-202453.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias